TNFSF11 and rheumatoid arthritis: This could for example be explained by the hypothesis that anti-TNFα might not only have suppressed inflammation but also osteclastogenesis, which is one of the major pathologic steps in RA pathogenesis [1], and the RANK-RANKL complex is a principal regulator and is activated in the early phase of osteoclast differentiation [29].